SynthesisBMC gastroenterology2024

Efficacy and safety of the combination of camrelizumab and apatinib in the treatment of liver cancer: a systematic review and single-arm meta-analysis.

Min Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.